CXCR3 and neoplasm: More specific inhibitors, such as SCH546738, which inhibits CXCR3-A but not the anti-tumoral CXCR3-B isoform, may have a more potent anti-tumor effect, since evidence suggests that it curbs tumor growth in GBM models while preserving the effects of CXCR3-B [23] (Fig. 3, Table 3).